Pre Seed · Biotech · Vienna, Austria · Founded 2024 · 11–50 employees
Graph Therapeutics is an Austrian techbio startup constructing an AI-powered drug discovery platform. The company integrates ex-vivo perturbation modeling from primary patient cell samples with multi-omics datasets to capture live immune biology. By training machine learning models on this clinical data, it aims to uncover novel therapeutic targets and biomarkers for inflammatory and immunological diseases. In January 2025, the venture secured a 3 million EUR pre-seed funding round to advance its precision immunology platform.